This is in contrast with the results obtained by Holmgaard and coworkers, who describe the first use of this model, and who describe an increased tumor growth rate after IDO1 overexpression, which is reduced by IDO1 inhibitor treatment (27). Here, IDO1 is linked to neoplasm.